Keyphrases
Confidence Interval
100%
Statins
74%
Netherlands
74%
Myocardial Infarction
64%
Pharmacogenetics
58%
Odds Ratio
55%
Dutch
47%
Acenocoumarol
46%
Meta-analysis
43%
Type 1 Diabetes Mellitus (T1DM)
43%
Angiotensin-converting Enzyme Inhibitor (ACEi)
40%
CYP2C9
36%
Phenprocoumon
36%
Drug Use
35%
Population-based Cohort Study
32%
Clopidogrel
32%
Genotype
31%
Antihypertensive Drugs
30%
Out-of-hospital Cardiac Arrest
30%
Pharmacoepidemiology
30%
VKORC1
29%
Hazard Ratio
29%
Randomized Controlled Trial
28%
Polymorphism
27%
Beta-blockers
27%
Type 2 Diabetes Mellitus (T2DM)
27%
Risk Factors
25%
Pharmacy Records
25%
Population-based Study
25%
Population-based Case-control Study
24%
Statin Therapy
24%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
24%
Coumarin
23%
Hip Fracture
22%
Vitamin K Antagonists
22%
Medication Use
21%
Proton Pump Inhibitors
21%
Hypertension
21%
Anticoagulation
20%
Fracture Risk
20%
ACE Inhibitors
20%
Clinical Trials
20%
Genetic Variation
20%
Atrial Fibrillation
20%
Non-inferiority Trial
19%
Angioedema
19%
Dosing Algorithm
19%
Total Hip Replacement
18%
Cost-effectiveness
18%
Incidence Rate
18%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
69%
Pharmacogenetics
66%
Heart Infarction
58%
Case-Control Study
56%
Dipeptidyl Carboxypeptidase Inhibitor
53%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
51%
Statin (Protein)
48%
Acenocoumarol
43%
Pharmacotherapy
43%
Prevalence
42%
Anticoagulant Agent
39%
Cerebrovascular Accident
38%
Randomized Controlled Trial
36%
Clinical Trial
34%
Phenprocoumon
33%
CYP2C9
32%
Clopidogrel
31%
Antihypertensive Agent
30%
Diseases
29%
Cardiovascular Disease
27%
Bleeding
26%
Beta Adrenergic Receptor Blocking Agent
26%
Antihypertensive Drug
23%
Non-Steroidal Anti-Inflammatory Drug
23%
Diabetes Mellitus
22%
Out of Hospital Cardiac Arrest
22%
Acetylsalicylic Acid
22%
Antiplatelet
20%
Hip Fracture
20%
Angioneurotic Edema
20%
Atrial Fibrillation
20%
Coumarin Derivative
20%
Antivitamin K
20%
Comorbidity
19%
Proton Pump Inhibitor
19%
Antidepressant
19%
Insulin Dependent Diabetes Mellitus
19%
CYP2C19
18%
Noninferiority Trial
18%
Non Insulin Dependent Diabetes Mellitus
17%
Community Pharmacy
16%
Pharmacokinetics
15%
Diuretics
15%
Femur Fracture
15%
Selective Serotonin Reuptake Inhibitor
14%
Chronic Obstructive Lung Disease
14%
Antithrombocytic Agent
14%
Brain Ischemia
14%
Observational Study
14%
Danaparoid
14%
Medicine and Dentistry
Cohort Analysis
43%
Case-Control Study
31%
Odds Ratio
26%
Knee Replacement
22%
Myocardial Infarction
22%
ACE Inhibitor
22%
Diabetes Mellitus
21%
Hip Replacement
21%
Maturity Onset Diabetes of the Young
20%
Meta-Analysis
19%
Systematic Review
19%
Diabetes
19%
Out of Hospital Cardiac Arrest
19%
Hazard Ratio
18%
Insulin Dependent Diabetes Mellitus
17%
Breast Cancer
16%
Medicine
16%
Nonsteroid Antiinflammatory Agent
15%
Asthma
15%
Diseases
15%
Drug Therapy
14%
Pharmacogenetics
13%
Cost-Effectiveness Analysis
13%
Chronic Obstructive Pulmonary Disease
12%
Antithrombotic
12%
Cardiovascular Disease
12%
Apoplexy
11%
Clinical Trial
10%
Essential Medicines
10%
Melanoma
10%
Platelet Reactivity
10%
Statin
10%
Health Care Cost
10%
Logistic Regression Analysis
9%
Prevalence
9%
Drug Use
9%
Low and Middle Income Countries
9%
Selective Serotonin Reuptake Inhibitor
9%
Vitamin K Antagonist
9%
Randomized Controlled Trial
9%
Clopidogrel
9%
Hip Fracture
9%
Primary Health Care
9%
Gastrointestinal Bleeding
9%
Antidiabetic Agent
9%
Atrial Fibrillation
8%
CYP2C19
8%
Cardiovascular System
8%
Oncology
8%
Proportional Hazards Model
8%
